For several days, it has been reported that President Trump is writing numerous Executive Orders (EO) to lower drug costs, along with addressing other issues.
The FDA Finally Decides IQOS Is a Harm Reduction Product
Philip Morris Products S.A.’s IQOS Tobacco Heating System can now be marketed as a tobacco harm reduction product.
Cancel Culture Goes After Famed Environmentalist
Michael Shellenberger’s new book, “Apocalypse Never: Why Environmental Alarmism Hurts Us All,” explains why most forms of renewable energy are bad for the environment and not practical for the world’s energy needs.
“Fixing” Healthcare … Again
This week, House Democrats brought to the floor H.R. 1425, with no bipartisan committee input and no amendments allowed.
Wasteful Spending on 340B Keeps Growing and Growing
Amid the COVID-19 pandemic response, the 340B drug safety-net program problems seem to have gotten lost.
Those Rising COVID-19 Numbers
On June 16, The Wall Street Journal published an opinion by Vice President Michael Pence, “There Isn’t a Coronavirus ‘Second Wave.'” The numbers show he is right.
Successes with Deregulation and COVID-19
In May, President Trump issued Executive Order (EO) 13924 to combat the economic consequences of the coronavirus.
The White House Has a Plan for Surprise Billing
The White House last night released its plan for solving the surprise billing issue, which has been a hot debate in Congress since late 2019.
Part D Senior Savings Model Shows Promise to Lower Insulin Costs
Medicare Part D Demonstration Model Shows Promise to Lower Insulin Costs for Seniors
Made in America and Wherever Else It May Be Necessary
There have been urgent calls to require pharmaceutical and medical device manufacturers to create all their products in the U.S. – but is that wise?